In-Depth article on ME/CFS Research Plans

MedPage Today’s Update on ME/CFS Research Plans

MedPage Today reposted Shannon Firth’s earlier article on ME/CFS in their 2015 recap and also published an in-depth update by the author. The new article goes in-depth on Ron Davis’ plans for the Big Data study and also includes an interview with Jen Brea and information from the NIH about their planned study of sudden-onset patients at the NIH Clinical Center.
Shannon Firth writes about Ron Davis’ rejections by NIH, OMF’s 2015 donations, and plans for the Big Data study:

Davis, who is also a professor of biochemistry and genetics at Stanford University School of Medicine, saw two grant proposals rejected by the agency and then chose a different tack: private funding. OMF has collected $1.9 million in private donations this year. Davis said that technology companies in Silicon Valley have also volunteered to help in the analysis phase of his project, known as the Severely Ill Big Data study, for free or at a low cost.

The article ends with Jen Brea’s thoughts on potential progress in understanding the disease:

Brea’s hopeful that with adequate public investment, scientists will see major progress in the next 5 to 10 years. She believes finding the reason for her condition might be relatively straight-forward.
But, she added, “[i]t’s really hard to find an answer for something, when you’re not looking.”

Read the entire article on MedPage Today.

Facebook
Twitter
WhatsApp
Email

Latest News

Blue square image with starbursts in the corners. the words, submit long covid drug recommendations to recover -tlc! are in the middle of the image, surrounded by thin white lines. the meaction logo is at the top of the image.

Submit Long COVID Drug Recommendations to RECOVER-TLC!

Last month, RECOVER TLC met at NIH headquarters in Bethesda. The goal was to initiate a drug development strategy for Long COVID clinical trials. Now, RECOVER TLC has opened the RECOVER-TLC Intervention Information Request Form, where you can make suggestions about which drugs and other interventions to trial!  Anyone can submit a therapeutic for consideration

Read More »
A classroom of people watching a panel discussion.

The RECOVER-Treating Long COVID (RECOVER TLC) The Path Forward

The RECOVER-Treating Long COVID (RECOVER TLC) Kick-off Meeting was Sept 23-25 in person and over Zoom. I had the privilege of attending over Zoom and Jaime Seltzer, #MEAction’s Scientific Director, represented the needs of the ME community in person and as an invited member of a panel on clinical trial design. There were many speakers

Read More »
Scroll to Top